These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2421306)

  • 1. The 2-5A system and vaccinia virus.
    Esteban M; Paez E
    Prog Clin Biol Res; 1985; 202():25-34. PubMed ID: 2421306
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of growth inhibition of DNA containing viruses by interferon: role of 2-5A.
    Sharma OK; Goswami BB; Cohrs RJ
    Prog Clin Biol Res; 1985; 202():317-24. PubMed ID: 2421310
    [No Abstract]   [Full Text] [Related]  

  • 3. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.
    Rice AP; Roberts WK; Kerr IM
    J Virol; 1984 Apr; 50(1):220-8. PubMed ID: 6422053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells.
    Silverman RH; Cayley PJ; Wreschner DH; Knight M; Gilbert CS; Brown RE; Kerr IM
    Tex Rep Biol Med; 1981-1982; 41():479-86. PubMed ID: 6189212
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of mitochondria in apoptosis induced by the 2-5A system and mechanisms involved.
    Domingo-Gil E; Esteban M
    Apoptosis; 2006 May; 11(5):725-38. PubMed ID: 16532271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2-5A system in control and interferon-treated K/BALB cells infected with encephalomyocarditis virus.
    Meurs E; Krause D; Robert N; Silverman RH; Hovanessian AG
    Prog Clin Biol Res; 1985; 202():307-15. PubMed ID: 2421309
    [No Abstract]   [Full Text] [Related]  

  • 7. Degradation of rRNA in interferon-treated vaccinia virus-infected cells.
    Goswami BB; Sharma OK
    J Biol Chem; 1984 Feb; 259(3):1371-4. PubMed ID: 6198324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 2',5'-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells.
    Rice AP; Kerr SM; Roberts WK; Brown RE; Kerr IM
    J Virol; 1985 Dec; 56(3):1041-4. PubMed ID: 2415713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon induced inhibition of enveloped viruses.
    Maheshwari RK; Friedman RM
    Prog Clin Biol Res; 1985; 202():297-305. PubMed ID: 2421308
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance of vaccinia virus to interferons: modulation of the 2-5A system in interferon-treated, vaccinia virus infected cells.
    Páez E; Esteban M
    Microbiologia; 1987 Oct; 3(3):163-78. PubMed ID: 2478164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of degradation products of 2-5A in the localized cleavage of viral RNA.
    Baglioni C; Williams GJ
    Prog Clin Biol Res; 1985; 202():275-83. PubMed ID: 3832073
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluorinated pyrimidines. 39. Effects of 5-trifluoromethyl-2'-deoxyuridine on the replication of vaccinia viral messenger ribonucleic acid and proteins.
    Oki T; Heidelberger C
    Mol Pharmacol; 1971 Nov; 7(6):653-62. PubMed ID: 5148900
    [No Abstract]   [Full Text] [Related]  

  • 13. Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated ppp(A2'p)nA-synthetase.
    Paez E; Esteban M
    Virology; 1984 Apr; 134(1):29-39. PubMed ID: 6324475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2-5A (pppA2'p5'A2'p5'A) and protein kinase systems in interferon-treated and control cells.
    Kerr IM; Wreschner DH; Silverman RH; Cayley PJ; Knight M
    Adv Cyclic Nucleotide Res; 1981; 14():469-78. PubMed ID: 6169260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular events in interferon-treated cells.
    Hovanessian AG
    Differentiation; 1979; 15(3):139-51. PubMed ID: 393560
    [No Abstract]   [Full Text] [Related]  

  • 16. RNA methylation in vaccinia virus-infected chick embryo fibroblasts treated with homologous interferon.
    Kroath H; Gross HJ; Jungwirth C; Bodo G
    Nucleic Acids Res; 1978 Jul; 5(7):2441-54. PubMed ID: 673858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of proteins and nucleic components of vaccinia virus].
    Kozlova IA; Mel'nikova LA
    Vopr Virusol; 1966; 11(4):387-92. PubMed ID: 4887655
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular mechanisms of action of interferon.
    Baglioni C; Nilsen TW; Maroney PA; de Ferra F
    Tex Rep Biol Med; 1981-1982; 41():471-8. PubMed ID: 6189211
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the (2'-5') oligoadenylate system by characterization of cells deficient in their response to interferon.
    Panet A; Arad G; Rappoport S; Hochman Y
    Prog Clin Biol Res; 1985; 202():345-50. PubMed ID: 2421313
    [No Abstract]   [Full Text] [Related]  

  • 20. Polyclonal antibody directed against 2-5A-dependent RNase.
    Dieffenbach CW; Krause D; Silverman RH
    Prog Clin Biol Res; 1985; 202():105-14. PubMed ID: 2421296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.